Pharmaceutical group

Cheplapharm

382 medicines7 countries

A group of 5 companies with 382 medicines in 7 countries.

Its medicines

Group structure

5 companies in 2 countries

Germany2

Switzerland1

Cheplapharm Schweiz GmbHAuthorisation holder · 2 medicines

Headquarters not stated2

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 382

Medicine	Substance	Country	Status	Authorised
ACCUTANE10 mg · Capsule	Isotretinoin	Canada	Marketed	1983
ACCUTANE40 mg · Capsule	Isotretinoin	Canada	Marketed	1983
ACTOCORTINA 373 mg POLVO PARA SOLUCIÓN INYECTABLE500 mg · Polvo para solución inyectable	Hydrocortisone	Spain	Marketed	1974
ACTOCORTINA 75 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE100 mg · Polvo y disolvente para solución inyectable	Hydrocortisone	Spain	Marketed	1958
Actos	Pioglitazone	EU (EMA)	Authorised	2000
ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido	Pioglitazone	Spain	Marketed	2002
ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido	Pioglitazone	Spain	Marketed	2001
ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido	Pioglitazone	Spain	Authorised	2001
ACTOS 15 mg COMPRIMIDOS15 mg · Comprimido	Pioglitazone	Spain	Authorised	2001
Actos 15 mg tablet, tablettenTablet	Pioglitazone	Netherlands	Authorised	2000
ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Marketed	2025
ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Marketed	2025
ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Authorised	2001
ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Marketed	2001
ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Marketed	2002
ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Authorised	2001
ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido	Pioglitazone	Spain	Marketed	2025
Actos 30 mg tablet, tablettenTablet	Pioglitazone	Netherlands	Authorised	2000
Actos 45 mg tablet, tablettenTablet	Pioglitazone	Netherlands	Authorised	2003
ANANDRON50 mg · Tablet	Nilutamide	Canada	Not marketed	1997
Anandron 150 mg, tablettenTablet	Nilutamide	Netherlands	Authorised	1996
Anexate, 0,5 mg/5 ml en 1,0 mg/ 10 ml oplossing voor injectieOplossing voor injectie	Flumazenil	Netherlands	Authorised	1988
Anexate 0,5 mg/5 ml otopina za injekciju/infuzijuotopina za injekciju/infuziju	Flumazenil	Croatia	Marketed	2016
ANEXATE 0,5 mg/5 ml SOLUCION INYECTABLE0,1 mg · Solución inyectable	Flumazenil	Spain	Marketed	1988
ANEXATE 1 mg/10 ml SOLUCION INYECTABLE1 mg · Solución inyectable	Flumazenil	Spain	Marketed	1988

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	162	152	10	Companies All medicines
Netherlands	105	105	0	Companies All medicines
Canada	60	56	4	Companies All medicines
Croatia	25	25	0	Companies All medicines
United States	14	14	0	Companies All medicines
European Union (EMA)	12	12	0	Companies All medicines
Romania	4	0	4	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 22 sources

INVIMA

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Germany

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.

Licence: commercial redistribution permission not established

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

BDPM / ANSM, HAS and UNCAM, France

BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Cheplapharm

Group structure

Germany2

Switzerland1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Cheplapharm

Group structure

Germany2

Switzerland1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇩🇪Germany2

🇨🇭Switzerland1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Group structure

🇩🇪Germany2

🇨🇭Switzerland1

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Germany2

Switzerland1

Germany2

Switzerland1